Human skin, lung and trachea produce human beta defensin-2 (hBD-2), an indu
cible, transcriptionally regulated antibiotic peptide with activity against
gram negative bacteria which may explain the unusual resistance of these t
issues to infection. Since an intact corneal epithelium is also highly resi
stant to infection, we examined whether human ocular surface epithelia migh
t produce hBD-2. Conjunctival epithelial cells were obtained from a human c
adaver eye, while corneal epithelial cells were obtained from both a cadave
r eye and the eye of a living human patient. Using reverse transcription-po
lymerase chain reaction and custom primers for hBD-2, a 257 bp sequence was
amplified from both human corneal and conjunctival epithelial cell cDNA, a
nd the amino acid sequence of this DNA band was computer-matched with the k
nown gene sequence of hBD-2 available through GenBank (Z71389). To determin
e whether bacterial by-products upregulate hBD-2 mRNA expression, we stimul
ated confluent SV 40-immortalized human corneal epithelial cells with bacte
rial culture supernatant prepared from either wild-type P. aeruginosa strai
n PAO1 or two different lipopolysaccharide (LPS) mutants of PAO1. Both of t
hese mutants, strains AK1012 and PAO1algC::tet, are deficient in phosphoman
nomutase activity which is required for the synthesis of both a complete po
lysaccharide core and the O side chain structures of the LPS molecule. Neit
her of these mutations affects the lipid A portion of LPS. Cells treated wi
th P. aeruginosa wild-type PAO1 bacterial culture supernatant demonstrated
strong upregulation of hBD-2 mRNA expression, whereas cells stimulated with
culture supernatant produced by either of the LPS mutants showed little or
no change in hBD-2 gene expression. LPS extracted from the bacterial cultu
re supernatant was used to demonstrate that upregulation of hBD-2 is caused
by LPS. Genistein blocked this upregulation suggesting that protein tyrosi
ne kinase activity is involved. Thus, both human corneal and conjunctival e
pithelium express mRNA for hBD-2, and this expression is upregulated by bac
terial LPS. Data obtained from LPS mutants suggest that lipid A, which is r
esponsible for initiating a number of the pathophysiological manifestations
induced by endotoxin in mammals, is not required. Stimulation of endogenou
s hBD-2 production via the active portion of LPS might have therapeutic pot
ential. (C) 1999 Academic Press.